Cost-Effectiveness of Meropenem Versus Standard-of-Care Antibiotics for Complicated Urinary Tract Infection and Acute Pyelonephritis in Saudi Arabia

Hammam Omar, Khalid Muammar, Fahad Alsultan, Zeyad

Open source

DOI
10.17605/osf.io/75ebw
Published
2026
Container
Not recorded
Publisher
OSF
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17605/osf.io/75ebw,
  title = {Cost-Effectiveness of Meropenem Versus Standard-of-Care Antibiotics for Complicated Urinary Tract Infection and Acute Pyelonephritis in Saudi Arabia},
  author = {Hammam Omar and Khalid Muammar and Fahad Alsultan and Zeyad},
  year = {2026},
  doi = {10.17605/osf.io/75ebw},
  url = {https://doi.org/10.17605/osf.io/75ebw}
}

RIS

TY  - JOUR
TI  - Cost-Effectiveness of Meropenem Versus Standard-of-Care Antibiotics for Complicated Urinary Tract Infection and Acute Pyelonephritis in Saudi Arabia
AU  - Hammam Omar
AU  - Khalid Muammar
AU  - Fahad Alsultan
AU  - Zeyad
PY  - 2026
DO  - 10.17605/osf.io/75ebw
UR  - https://doi.org/10.17605/osf.io/75ebw
ER  - 

APA

Omar, H., Muammar, K., Alsultan, F., & Zeyad (2026). Cost-Effectiveness of Meropenem Versus Standard-of-Care Antibiotics for Complicated Urinary Tract Infection and Acute Pyelonephritis in Saudi Arabia. https://doi.org/10.17605/osf.io/75ebw

Source records